Abstract: A computer-readable recording medium stores therein an abnormality cause estimating program causing a computer to execute a process. The process includes acquiring load information of a system; determining whether or not the system indicates abnormality based on the load information, and specifying a first function group which includes one or a plurality of functions executed by the system when the determination indicates that the system indicates the abnormality and specifying a second function group which includes one or a plurality of functions executed by the system when the determination indicates that the system does not indicate abnormality; and outputting information of a function which is not included in the second function group among the functions included in the first function group.

Abstract: According to one aspect, a non-transitory computer-readable recording medium stores therein a log acquisition program causing a computer to execute a process. The process includes receiving information for designating multiple functions of an application for which logs are to be acquired and designating a log detail level with respect to each of the multiple functions; and acquiring a log of the application with a corresponding log detail level with respect to each of the multiple functions designated.

Abstract: A solder drawing member (402) is detachably attached on the outer side of a jet nozzle (303) that jets molten solder pumped from a solder tank (102) storing the molten solder. The solder drawing member (402) is made of a material having higher wettability to the molten solder than the surface material of the jet nozzle (303). Thus a force of separating the solder from a point to be soldered can be increased by a surface tension of the molten solder flowing on the solder drawing member (402), thereby reducing bridge phenomena and icicle phenomena.

Abstract: A 1,2,3,4-tetrahydroquinoxaline compound represented by the following formula: In the formula (1), R1 represents substituents such as a halogen, an alkyl, a cycloalkyl, an aryl or a heterocyclic group; p represents 0 to 5; R2 represents substituents such as a halogen, an alkyl, a hydroxyl or an alkoxy group; q represents 0 to 2; R3 represents substituents such as hydrogen, an alkyl, an alkenyl, an alkylcarbonyl or an arylcarbonyl group; R4 and R5 independently represent substituents such as hydrogen, a halogen, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl or a heterocyclic group; R6 represents substituents such as hydrogen, an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl or a heterocyclic group; A represents an alkylene; R7 represents OR8, NR8R9, SR8, S(O)R8, S(O)2R8; R8 and R9 independently represent substituents such as hydrogen, an alkyl or an alkenyl; and X represents O or S.

Abstract: A work apparatus includes a drive motor, a tool head including a tool frame, a bearing, a tool shaft and a rotary tool, a frame tube with the proximal end connected to the drive motor and the distal end connected to the tool head, and a drive shaft rotatably inserted through the frame tube for transmitting the rotation of the drive motor to the rotary tool. The rotary tool is accommodated within the tool frame and is rotatable on the tool shaft, when driven by the drive shaft. The tool shaft is journaled by the bearing which is elastically supported by a flexible elastic member disposed coaxially around the bearing and interposed between the bearing and the connection of the tool frame or the frame tube. Undesirable vibrations caused by the rotation of the rotary tool will be effectively hindered from being transmitted to the frame tube.

Abstract: An object of the present invention is to synthesize a novel 1,2,3,4-tetrahydroquinoxaline derivative represented by formula (1) and to find a pharmacological action of the derivative. In the formula, the R1 represents a halogen, an alkyl, cycloalkyl, aryl or heterocyclic group, or the like; p represents 0 to 5; R2 represents a halogen, an alkyl, hydroxyl or alkoxy group, or the like; q represents 0 to 2; R3 represents hydrogen, an alkyl, alkenyl, alkylcarbonyl or arylcarbonyl group, or the like; R4 and R5 independently represent hydrogen, a halogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; R6 represents hydrogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; A represents an alkylene; R7 represents OR8, NR8R9, SR8, S(O)R8, S(O)2R8; and X represents O or S.

Abstract: A compound having the following formula [I] or a pharmaceutically acceptable salt thereof: wherein A is an aromatic five-membered heterocycle which optionally is fused with a cycloalkane ring; B is an alkylene; R1 and R2 are hydrogen, hydroxyl, alkoxy, aryloxy, alkyl, cycloalkyl, aryl, heterocycle, amino, alkylamino, arylamino or acyl, or R1 and R2 join together to form a heterocycle; X and Y are hydrogen, halogen, hydroxyl, alkoxy, aryloxy, alkyl, cycloalkyl, aryl, mercapto, alkylthio, arylthio, carboxyl, an ester of carboxyl, an amide of carboxyl, cyano or nitro; p is 0, 1 or 2; and q is 0 or 1. The compound is useful for treating diseases in which angiogenesis or augmentation of vascular permeability is involved.

Abstract: A diffuser apparatus which has fine pores is capable of achieving a high oxygen transfer efficiency and rarely becoming clogged so that the apparatus can be operated stably over a prolonged period. The diffuser apparatus includes: an aeration plate that is disposed in an aeration tank in order to release pressurized air, fed from a diffusing air feed pipe, as air bubbles from fine pores formed in an aeration plate surface; blow water feeder for feeding blow water into the diffusing air feed pipe; and an inserted pipe for discharging the blow water, fed into the diffusing air feed pipe, from the aeration plate.

Abstract: A method of treating a disease associated with angiogenesis by administering a therapeutically effective amount of a compound represented by the formula (1) or a salt thereof wherein the ring X represents R1 and R2 independently represent a hydrogen atom, an alkyl, an aryl or an aromatic heterocyclic; R3 represents a hydrogen atom, a halogen atom, a hydroxy, an alkoxy, an aryloxy, an alkyl, an aryl, an amino, an alkylamino, a cycloalkylamino, an arylamino, an alkylcarbonylamino, an arylcarbonylamino, a mercapto, an alkylthio, an arylthio, an alkylsulfinyl or a nonaromatic heterocyclic; A1 represents a sulfur atom, a sulfinyl or a sulfonyl; and A2 represents an alkylene.

Abstract: According to one embodiment, a disk drive writes, upon receiving a first write data block in a plurality of write data blocks having continuous logical block addresses, the first write data block in a first storage location which is included in a specific area on a disk and is adjacent to a position of the head, and writes a second write data block in a second storage location which is included in the specific area and is adjacent to the position of the head. The second storage location is a storage location skipped from the first storage location by an interval corresponding to a difference between a write completion timing of the first write data block and a reception timing of the second write data block.

Abstract: An indole compound having a carbamoyl group, a ureido group and a substituted oxy group having the following formula (1) or a salt thereof: In the formula (1), R1 represents a hydrogen atom, an alkyl group, a hydroxy group, or an alkoxy group; R2 represents a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group, or a heterocyclic group; R3 represents a halogen atom, an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group, a heterocyclic group an alkoxy group, an alkenyloxy group, an alkynyloxy group, a cycloalkyloxy group, an aryloxy group or a heterocyclic oxy group; m represents 0, 1, 2, or 3.

Abstract: A printer includes a first case and a second case, a paper containing portion is formed in the first case and contains a paper roll, a paper holder is provided in the paper containing portion and hold the paper roll, a pair of supporting members are provided in the paper holder and hold both ends of the paper roll, with each of the supporting members holding one of the ends, a contacting portion is provided in the paper holder and is thicker than are the supporting members, and a first projection projects in the paper containing portion from the first case toward the paper holder and is positioned, in the axial direction of the paper roll, between the contacting portion and a wall surface of the first case located on the side of the contact portion and is able to come into contact with the contacting portion.

Abstract: A method of preventing or treating a glucocorticoid receptor-related disease involving administering a therapeutically effective amount of a 1,2-dihydroquinoline compound or a pharmaceutically acceptable salt thereof.

Abstract: A reduced size vacuum die-casting machine wherein an amount of powder release agent which is fed to a mold cavity each time is stable and loss of velocity of the air flow for sucking out the powder release agent is difficult, the apparatus provided with a powder control valve which has a powder release agent passage through which a powder release agent passes and which moves back and forth inside of a sleeve to switch between a state communicating a discharge hole with a molten metal holding chamber and a state communicating a discharge hole with a powder release agent passage, the powder release agent passage of the powder control valve formed inside of the powder control valve, the inlet and outlet of the powder release agent passage being formed at the outer surface of the powder control valve.

Abstract: The invention provides flaky titanic acid having polymerizable functional groups, a suspension of the same, titanic acid coating films excellent in tight adhesion, and resin bases with titanic acid coating films, namely, flaky titanic acid obtained by treating a layered titanate with an acid and then making an organic basic compound act on the obtained product to conduct interlaminar swelling or delamination, characterized in that at least part of the organic basic compound is one having a polymerizable functional group such as acryl or methacryl and, preferably, in that the layered titanate is one represented by the general formula: AxMy?zTi2-(y+z)O4 [wherein A and M are different from each other and are each a mono- to tri-valent metal; ? represents a Ti-defective site; x is a positive real number satisfying the relationship: 0<x<1; and y and z are 0 or positive real numbers satisfying the relationship: 0<y+z<1].

Abstract: An object is to provide an equipment parameter setting support system for supporting the setting of parameters in various processing equipment.

Abstract: Disclosed is a hydrophilic polyolefin sintered material which is a water-absorbing sintered material of a polyolefin resin ice having a graft chain composed of at least one molecular chain selected from hydrophilic ethylenically unsaturated group-containing monomers and their polymers. This hydrophilic polyolefin sintered material has an average porosity of 20-80% by volume and an open cell having an average pore diameter of 1-150 ?m.

Abstract: A compound of formula (1): wherein R1 and R2 represent hydrogen, lower alkyl, lower alkenyl, lower alkynyl or R3 represents hydroxyl, lower alkoxy, lower cycloalkyloxy, aryloxy, carboxy, lower alkoxycarbonyl, or NRaRb of the formula R4 and R5 represent halogen, lower alkyl, hydroxyl, or lower alkoxy; R6 represents halogen, lower alkyl, aryl, heterocyclic, hydroxy, lower alkoxy, mercapto, lower alkylthio, lower alkylcarbonyl, amino, nitro or cyano; R7 represents lower alkyl, hydroxyl or lower alkoxy; Ra and Rb represent hydrogen or lower alkyl; ring A represents a cyclic hydrocarbon or a heterocyclic ring; ring B represents a heterocyclic ring; X represents lower alkylene; Z represents a single bond or lower alkylene; Y represents lower alkylene and W1—W2 represents CH—CH, or Y represents a single bond and W1—W2 represents N—CH, CH—N or CH—CH; and 1, m, n and o represent 0, 1, 2, or 3.

Abstract: Disclosed are: a compatibilizing agent for a polymer alloy, which can increase the compatibility with a variety of polymers; a polymer alloy using the compatibilizing agent; and master batch for a polymer alloy. Specifically disclosed is a compatibilizing agent which is used for the preparation of a polymer alloy by blending at least one polymer (A) selected from the group consisting of a polyphenylene sulfide, a polyphenylene ether and a polyamide with a polymer (B) of a different type from the polymer (A) at such a ratio that the amount of the polymer (A) blended is the same as or more than that of the polymer (B). The compatibilizing agent comprises a nanosheet-shaped layered titanic acid which is produced by intercalate an organic basic compound between the layers of a layered titanic acid.

Abstract: A compound of formula (1): wherein R1 and R2 represent hydrogen, lower alkyl, lower alkenyl, lower alkynyl or R3 represents hydroxyl, lower alkoxy, lower cycloalkyloxy, aryloxy, carboxy, lower alkoxycarbonyl, or NRaRb of the formula R4 and R5 represent halogen, lower alkyl, hydroxyl, or lower alkoxy; R6 represents halogen, lower alkyl, aryl, heterocyclic, hydroxy, lower alkoxy, mercapto, lower alkylthio, lower alkylcarbonyl, amino, nitro or cyano; R7 represents lower alkyl, hydroxyl or lower alkoxy; Ra and Rb represent hydrogen or lower alkyl; ring A represents a cyclic hydrocarbon or a heterocyclic ring; ring B represents a heterocyclic ring; X represents lower alkylene; Z represents a single bond or lower alkylene; Y represents lower alkylene and W1-W2 represents CH—CH, or represents a single bond and W1-W2 represents N—CH, CH—N or CH—CH; and 1, m, n and o represent 0, 1, 2, or 3.